{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:41:13Z","timestamp":1778859673897,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T00:00:00Z","timestamp":1452124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00296-015-3417-8","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T09:21:45Z","timestamp":1452158505000},"page":"579-584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["The IL-33 gene is related to increased susceptibility to systemic sclerosis"],"prefix":"10.1007","volume":"36","author":[{"given":"Suleyman Serdar","family":"Koca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yavuz","family":"Pehlivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Kara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Alibaz-Oner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdar","family":"Oztuzcu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neslihan","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gozde Yildirim","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bunyamin","family":"Kisacik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Metin","family":"Ozgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer Nuri","family":"Pamuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haner","family":"Direskeneli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Sayarlioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Mesut","family":"Onat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,7]]},"reference":[{"key":"3417_CR1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11926-012-0297-8","volume":"15","author":"MB Greenblatt","year":"2013","unstructured":"Greenblatt MB, Aliprantis AO (2013) The immune pathogenesis of scleroderma: context is everything. Curr Rheumatol Rep 15:297","journal-title":"Curr Rheumatol Rep"},{"key":"3417_CR2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.cyto.2011.08.030","volume":"56","author":"P Fuschiotti","year":"2011","unstructured":"Fuschiotti P (2011) Role of IL-13 in systemic sclerosis. Cytokine 56:544\u2013549","journal-title":"Cytokine"},{"key":"3417_CR3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","volume":"23","author":"J Schmitz","year":"2005","unstructured":"Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23:479\u2013490","journal-title":"Immunity"},{"key":"3417_CR4","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1002\/1521-4141(2002010)32:10<2979::AID-IMMU2979>3.0.CO;2-5","volume":"32","author":"S L\u00e9cart","year":"2002","unstructured":"L\u00e9cart S, Lecointe N, Subramaniam A, Alkan S, Ni D, Chen R, Boulay V, P\u00e8ne J, Kuroiwa K, Tominaga S, Yssel H (2002) Activated, but not resting human Th2 cells, in contrast to Th1 and T regulatory cells, produce soluble ST2 and express low levels of ST2L at the cell surface. Eur J Immunol 32:2979\u20132987","journal-title":"Eur J Immunol"},{"key":"3417_CR5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2332\/allergolint.10-RAI-0186","volume":"59","author":"K Oboki","year":"2010","unstructured":"Oboki K, Ohno T, Kajiwara N, Saito H, Nakae S (2010) IL-33 and IL-33 receptors in host defense and diseases. Allergol Int 59:143\u2013160","journal-title":"Allergol Int"},{"key":"3417_CR6","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1002\/eji.200737547","volume":"37","author":"M Komai-Koma","year":"2007","unstructured":"Komai-Koma M, Xu D, Li Y, McKenzie AN, McInnes IB, Liew FY (2007) IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol 37:2779\u20132786","journal-title":"Eur J Immunol"},{"issue":"8","key":"3417_CR7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","volume":"4","author":"TA Wynn","year":"2004","unstructured":"Wynn TA (2004) Fibrotic disease and the T(H)1\/T(H)2 paradigm. Nat Rev Immunol 4(8):583\u2013594","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"3417_CR8","first-page":"328","volume":"24","author":"M Hasegawa","year":"1997","unstructured":"Hasegawa M, Fujimoto M, Kikuchi K, Takehara K (1997) Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J Rheumatol 24(2):328\u2013332","journal-title":"J Rheumatol"},{"key":"3417_CR9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/art.1780350111","volume":"35","author":"BW Needleman","year":"1992","unstructured":"Needleman BW, Wigley FM, Stair RW (1992) Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma. Arthritis Rheum 35:67\u201372","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3417_CR10","first-page":"1751","volume":"151","author":"C Mavalia","year":"1997","unstructured":"Mavalia C, Scaletti C, Romagnani P, Carossino AM, Pignone A, Emmi L, Pupilli C, Pizzolo G, Maggi E, Romagnani S (1997) Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. Am J Pathol 151(6):1751\u20131758","journal-title":"Am J Pathol"},{"issue":"3","key":"3417_CR11","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.4049\/jimmunol.0903306","volume":"184","author":"AL Rankin","year":"2010","unstructured":"Rankin AL, Mumm JB, Murphy E, Turner S, Yu N, McClanahan TK, Bourne PA, Pierce RH, Kastelein R, Pflanz S (2010) IL-33 induces IL-13-dependent cutaneous fibrosis. J Immunol 184(3):1526\u20131535","journal-title":"J Immunol"},{"issue":"10","key":"3417_CR12","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1136\/ard.2010.148247","volume":"70","author":"M Manetti","year":"2011","unstructured":"Manetti M, Guiducci S, Ceccarelli C, Romano E, Bellando-Randone S, Conforti ML, Ibba-Manneschi L, Matucci-Cerinic M (2011) Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement. Ann Rheum Dis 70(10):1876\u20131878","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"3417_CR13","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s10067-011-1686-5","volume":"30","author":"K Yanaba","year":"2011","unstructured":"Yanaba K, Yoshizaki A, Asano Y, Kadono T, Sato S (2011) Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. Clin Rheumatol 30(6):825\u2013830","journal-title":"Clin Rheumatol"},{"issue":"1","key":"3417_CR14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/annrheumdis-2012-201553","volume":"72","author":"S Terras","year":"2013","unstructured":"Terras S, Opitz E, Moritz RK, H\u00f6xtermann S, Gambichler T, Kreuter A (2013) Increased serum IL-33 levels may indicate vascular involvement in systemic sclerosis. Ann Rheum Dis 72(1):144\u2013145","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3417_CR15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1445-5994.1999.tb01586.x","volume":"29","author":"H Englert","year":"1999","unstructured":"Englert H, Small-McMahon J, Chambers P, O\u2019Connor H, Davis K, Manolios N, White R, Dracos G, Brooks P (1999) Familial risk estimation in systemic sclerosis. Aust N Z J Med 29(1):36\u201341","journal-title":"Aust N Z J Med"},{"issue":"6","key":"3417_CR16","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S","volume":"44","author":"FC Arnett","year":"2001","unstructured":"Arnett FC, Cho M, Chatterjee S, Aguilar MB, Reveille JD, Mayes MD (2001) Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum 44(6):1359\u20131362","journal-title":"Arthritis Rheum"},{"key":"3417_CR17","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1111\/j.1365-2222.2008.03114.x","volume":"38","author":"M Sakashita","year":"2008","unstructured":"Sakashita M, Yoshimoto T, Hirota T, Harada M, Okubo K, Osawa Y, Fujieda S, Nakamura Y, Yasuda K, Nakanishi K, Tamari M (2008) Association of serum interleukin-33 level and the interleukin-33 genetic variant with Japanese cedar pollinosis. Clin Exp Allergy 38:1875\u20131881","journal-title":"Clin Exp Allergy"},{"key":"3417_CR18","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/mp.2009.10","volume":"14","author":"J Chapuis","year":"2009","unstructured":"Chapuis J, Hot D, Hansmannel F, Kerdraon O, Ferreira S, Hubans C et al (2009) Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer\u2019s disease. Mol Psychiatry 14:1004\u20131016","journal-title":"Mol Psychiatry"},{"issue":"2","key":"3417_CR19","doi-asserted-by":"crossref","first-page":"R105","DOI":"10.1186\/ar4554","volume":"16","author":"C Li","year":"2014","unstructured":"Li C, Mu R, Guo J, Wu X, Tu X, Liu X, Hu F, Guo S, Zhu J, Xu H, Li Z (2014) Genetic variant in IL33 is associated with susceptibility to rheumatoid arthritis. Arthritis Res Ther 16(2):R105","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"3417_CR20","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3109\/03009742.2014.882408","volume":"43","author":"D Fan","year":"2014","unstructured":"Fan D, Ding N, Yang T, Wu S, Liu S, Liu L, Hu Y, Duan Z, Xia G, Xu S, Xu J, Ding C, Pan F (2014) Single nucleotide polymorphisms of the interleukin-33 (IL-33) gene are associated with ankylosing spondylitis in Chinese individuals: a case\u2013control pilot study. Scand J Rheumatol 43(5):374\u2013379","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"3417_CR21","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00296-014-3111-2","volume":"35","author":"SS Koca","year":"2015","unstructured":"Koca SS, Kara M, Deniz F, Ozgen M, Demir CF, Ilhan N, Isik A (2015) Serum IL-33 level and IL-33 gene polymorphisms in Beh\u00e7et\u2019s disease. Rheumatol Int 35(3):471\u2013477","journal-title":"Rheumatol Int"},{"issue":"11","key":"3417_CR22","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Hoogen van den","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum 65(11):2737\u20132747","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3417_CR23","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/ard.60.6.592","volume":"60","author":"G Valentini","year":"2001","unstructured":"Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman AJ, D\u2019Angelo S et al (2001) European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 60(6):592\u2013598","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"3417_CR24","first-page":"2159","volume":"26","author":"TA Medsger Jr","year":"1999","unstructured":"Medsger TA Jr, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA et al (1999) A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 26(10):2159\u20132167","journal-title":"J Rheumatol"},{"issue":"2","key":"3417_CR25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.cr.7290272","volume":"15","author":"YY Shi","year":"2005","unstructured":"Shi YY, He L (2005) SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15(2):97\u201398","journal-title":"Cell Res"},{"issue":"Suppl 2","key":"3417_CR26","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/ar2188","volume":"9","author":"T Krieg","year":"2007","unstructured":"Krieg T, Abraham D, Lafyatis R (2007) Fibrosis in connective tissue disease: the role of the myofibroblast and fibroblast-epithelial cell interactions. Arthritis Res Ther 9(Suppl 2):S4","journal-title":"Arthritis Res Ther"},{"key":"3417_CR27","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/01.bor.0000139310.77347.9c","volume":"16","author":"AE Postlethwaite","year":"2004","unstructured":"Postlethwaite AE, Shigemitsu H, Kanangat S (2004) Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis. Curr Opin Rheumatol 16:733\u2013738","journal-title":"Curr Opin Rheumatol"},{"key":"3417_CR28","first-page":"167","volume":"4","author":"FL Veerdonk Van de","year":"2013","unstructured":"Van de Veerdonk FL, Netea MG (2013) New insights in the immunobiology of IL-1 family members. Front Immunol 4:167","journal-title":"Front Immunol"},{"key":"3417_CR29","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/ard.2009.119321","volume":"69","author":"M Manetti","year":"2010","unstructured":"Manetti M, Ibba-Manneschi L, Liakouli V, Guiducci S, Milia AF, Benelli G et al (2010) The IL1-like cytokine IL-33 and its receptor ST2 are abnormally espresse in the affected skin and visceral organs of patients with systemic sclerosis. Ann Rheum Dis 69:598\u2013605","journal-title":"Ann Rheum Dis"},{"key":"3417_CR30","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.4049\/jimmunol.179.4.2551","volume":"179","author":"AA Chackarian","year":"2007","unstructured":"Chackarian AA, Oldham ER, Murphy EE, Schimtz J, Pflanz S, Kastelein RA et al (2007) IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol 179:2551\u20132555","journal-title":"J Immunol"},{"issue":"3","key":"3417_CR31","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/gene.2013.7","volume":"14","author":"H Luo","year":"2013","unstructured":"Luo H, Higuchi K, Matsumoto K, Mori M (2013) An interleukin-33 gene polymorphism is a modifier for eosinophilia in rats. Genes Immun 14(3):192\u2013197","journal-title":"Genes Immun"},{"issue":"7","key":"3417_CR32","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00439-011-1137-z","volume":"131","author":"JE Mart\u00edn","year":"2012","unstructured":"Mart\u00edn JE, Bossini-Castillo L, Mart\u00edn J (2012) Unraveling the genetic component of systemic sclerosis. Hum Genet 131(7):1023\u20131037","journal-title":"Hum Genet"},{"issue":"5","key":"3417_CR33","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ng.565","volume":"42","author":"TR Radstake","year":"2010","unstructured":"Radstake TR, Gorlova O, Rueda B, Martin JE, Alizadeh BZ, Palomino-Morales R et al (2010) Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet 42(5):426\u2013429","journal-title":"Nat Genet"},{"issue":"7","key":"3417_CR34","doi-asserted-by":"crossref","first-page":"e1002091","DOI":"10.1371\/journal.pgen.1002091","volume":"7","author":"Y Allanore","year":"2011","unstructured":"Allanore Y, Saad M, Dieud\u00e9 P, Avouac J, Distler JH, Amouyel P et al (2011) Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis. PLoS Genet 7(7):e1002091","journal-title":"PLoS Genet"},{"issue":"7","key":"3417_CR35","doi-asserted-by":"crossref","first-page":"e1002178","DOI":"10.1371\/journal.pgen.1002178","volume":"7","author":"O Gorlova","year":"2011","unstructured":"Gorlova O, Martin JE, Rueda B, Koeleman BP, Ying J, Teruel M et al (2011) Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. PLoS Genet 7(7):e1002178","journal-title":"PLoS Genet"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-015-3417-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-015-3417-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-015-3417-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:28:35Z","timestamp":1559042915000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-015-3417-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,7]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["3417"],"URL":"https:\/\/doi.org\/10.1007\/s00296-015-3417-8","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,7]]}}}